Alfuzosin
Back to searchMolecule Structure
Scientific Name
Alfuzosin
Description of the Drug
Alfuzosin is an alpha-1 adrenergic antagonist used in the symptomatic management of benign prostatic hypertrophy (BPH).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00346
http://www.drugbank.ca/drugs/DB00346
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Concordia Pharmaceuticals Inc, Invagen Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Atlantide Pharmaceuticals Ag, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Unichem Laboratories Ltd, Torrent Pharmaceuticals Ltd., Heritage Pharma Labs Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-1 | PROTEIN FAMILY | AGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34477 | ||
| PharmGKB | PA164774795 | ||
| Human Metabolome Database | HMDB0014490 | ||
| DrugBank | DB00346 | ||
| PubChem: Thomson Pharma | 14805133 | ||
| PubChem | 2092 | ||
| Mcule | MCULE-9094645643 | ||
| LINCS | LSM-1291 | ||
| Nikkaji | J34.501F | ||
| BindingDB | 50033110 | ||
| EPA CompTox Dashboard | DTXSID6048549 | ||
| DrugCentral | 115 | ||
| ChemicalBook | CB4332422 | ||
| Guide to Pharmacology | 7109 | ||
| rxnorm | ALFUZOSIN | UROXATRAL | ALFUZOSIN HYDROCHLORIDE |
| ChEBI | 51141 |
